Clinical trial
Decreasing Postoperative Blood Loss and Seizures by Timing of Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION)-2 Pilot Trial
NCT06622564 is registered in ClinicalTrials.gov with Hamilton Health Sciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Decreasing Postoperative Blood Loss and Seizures by Timing of Intravenous Tranexamic Acid in Open Cardiac Surgery (DEPOSITION)-2 Pilot Trial
- Lead sponsor
- Hamilton Health Sciences Corporation
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- January 1, 2025
- Completion date
- February 1, 2026
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bleeding, seizures, surgical blood loss